Ilyang Pharmaceutical Co.,Ltd

Research Ilyang Pharmaceutical Co.,Ltd (007570.KS) on Bullrun: market cap KRW 130.85B, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 130.85B; dividend yield is 2.1%.

Peer valuation comparison

Latest dividend yield is 2.12% versus a Healthcare sector median of 1.81% (17.1% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-16KRW 130.85Bn/a2.1%155

Dividend history

Latest trailing dividend snapshot: annual dividend/share 155 KRW, yield 2.1%.

About Ilyang Pharmaceutical Co.,Ltd

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Sinil Pharmaceutical Co., Ltd. (012790.KQ) CMG Pharmaceutical Co., Ltd. (058820.KQ) HLB Co., Ltd. (028300) Celltrion, Inc. (068270) ALTEOGEN Inc. (196170) Samsung Biologics Co.,Ltd. (207940) IVIM Technology, Inc (460470.KQ) Lee's Pharmaceutical Holdings Limited (0950.HK) Cannovum Cannabis AG (27N0.DE) Takeda Pharmaceutical Company Limited (4502) AB SCIENCE (AB.PA) AFT Pharmaceuticals Limited (AFP.AX)

Frequently asked questions

What is Ilyang Pharmaceutical Co.,Ltd's market cap?

Ilyang Pharmaceutical Co.,Ltd's market capitalization is KRW 130.85B.

Does Ilyang Pharmaceutical Co.,Ltd pay a dividend?

Ilyang Pharmaceutical Co.,Ltd has a dividend yield of 2.1%.

What does Ilyang Pharmaceutical Co.,Ltd do?

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.